DRD2 and diffuse intrinsic pontine glioma: There were some preclinical data supportive of DRD2 antagonistic activity [286], and the clinical activity seen in diffuse intrinsic pontine gliomas (DIPG) has been suggested to be mediated through DRD2 inhibition [288,289].